¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2022-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2022-09-03
±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : ÀüÁÖ ÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ, ¼¼¹Ì³ª½Ç  
±³À°ÁÖÁ¦ : 2022³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ (ÀÌ»çÀåÁ¦)  
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 070-4888-5731  
À̸ÞÀÏ : ksbtp.svc@gmail.com      
±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : Àü¶óºÏµµ
±³À°½Ã°£ : 12 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï-Àü¹®ÀÇ 40,000¿ø/±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 20,000¿ø/°£È£»ç,ÀÓ»ó½É¸®»ç,»çȸº¹Áö»ç 20,000¿ø/Æò»ýȸ¿ø-¸éÁ¦ ÇöÀåµî·Ï-¾øÀ½      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 09:25~09:50 Depression and anxiety during COVID-19  Àå¿ÁÁø(±¹¸³ºÎ°îº´¿ø) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 09:50~10:15 The potential impact of COVID-19 on psychosis  ÃµÀºÁø(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 10:15~10:40 The impact of the COVID-19 pandemic on the mental health of Koreans  Á¤¼º¿ø(°è¸íÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 10:40~10:50 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 11:00~11:25 Psychotic symptoms in dementia  ¼ÛÁ¦Çå(±¹¸³³ªÁÖº´¿ø) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 11:25~11:50 Mood and affective symptoms in dementia  ÀÓÀº¼º(È¿»ç¶ûº´¿ø) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 11:50~12:15 Sleep disturbance in dementia  ¹æ¿µ·Õ(¿ï»êÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 12:15~12:25 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 12:30~13:05 Effectiveness of Switching to Long-acting Injectable Aripiprazole in Patients with Recent-onset and Chronic Schizophrenia  ±è¼º¿Ï(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 13:05~13:40 Improving Outcomes of Bipolar Disorder with Long-acting-Injectable Antipsychotics Treatment: Impact on Patients and Careers  Àå¼¼Çå(±è¿ø¹¬±â³äºÀ»ýº´¿ø) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 13:40~14:05 Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality  À̽ÂÀç(°æºÏÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 14:05~14:30 Effects of drug therapy as an early intervention in psychotic disorders  À̺´´ë(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 14:30~14:55 Mindlink: A stigma-free youth-friendly community-based early-intervention centre in Korea  ±è¼º¿Ï(Àü³²ÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 14:55~15:05 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 15:15~15:40 Glucose Metabolism and Obesity in Bipolar Disorder  ¼ºÇü¸ð(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 15:40~16:05 Molecular Biological Association between Bipolar Disorder and Obesity  ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 16:05~16:30 Development of a new treatment target for bipolar disorder in the mechanism of action of antidiabetic drugs  °­ÇÑ°íÀººñ(±¹¸³³ªÁÖº´¿ø) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç À¯Ç×°ËȦ 16:30~16:40 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 09:25~09:50 The role of dopamine in the schizophrenia and mood disorder  °­Å¿í(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 09:50~10:15 Serotonergic and noradrenergic systems in depression and anxiety disorder  ÀÌ»ó¿ø(°æºÏÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 10:15~10:40 Update of other neurotransmitters: glutamate, GABA, acetylcholine  Àü¼Ò¿¬(Ãæ³²ÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 10:40~10:50 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 11:00~11:25 The general medical conditions causing psychotic symptom  ±è°æ¿ø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 11:25~11:50 Conditions that affect cognitive function  Àå½ÂÈ£(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 11:50~12:15 The effects of acute and chronic stress  ¼­È­±Ô(ºÎ»êÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 12:15~12:25 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 13:40~14:05 Schizoaffective disorder  À±¼®È£(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 14:05~14:30 Schizophrenia and OCD  À±ÇüÁØ(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 14:30~14:55 Schzophrenia and autism spectrum disorder  ¾çÂù¸ð(¿ø±¤ÀÇ´ë) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 14:55~15:05 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 15:15~15:40 COVID-19 and psychoimmunology  ¹®Àº¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 15:40~16:05 Safety of psychiatric medications in COVID-19  ÀÌÁ¤¾È(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 16:05~16:30 The effectiveness of telepsychiatry  È«Á¤¿Ï(Àͻ꺴¿ø) 
Åä·Ð 09-03 ÀüÁÖÆòÈ­ÀÇÀü´ç ¼¼¹Ì³ª½Ç 16:30~16:40 ÁúÀÇ ¹× Åä·Ð  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2022-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³â ´ëÇѹ财Àå¾Ö¿ä½Ç±ÝÇÐȸ Á¦27Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2022-09-03
´ÙÀ½±Û ¸¸¼ºÄáÆϺ´ ¹Ì³×¶ö-»ÀÁúȯ ¿¬±¸È¸ (¿Â¶óÀÎ) 2022 CKD-MBD ¿¬±¸È¸ ¿¬¼ö°­Á (18Â÷) : 2022-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20983 °æ³² 2024 ÁøÁÖ½ÃÀÇ»çȸ »ó¹Ý±â Àǻ翬¼ö±³À° : 2024-06-22 0 6 2024-06-14
20982 °æ±â °¡Å縯´ëÇб³ÀÇÁ¤ºÎ¼º¸ðº´¿ø Á¦ 8Â÷ °æ±âºÏºÎ °³¿øÀǸ¦ À§ÇÑ Çмú´ëȸ : 2024-06-22 0 10 2024-06-14
20981 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-22 0 10 2024-06-14
20980 ¼­¿ï ´ëÇÑÈĵÎÀ½¼º¾ð¾îÀÇÇÐȸ 11ȸ °ø¿¬¹ß¼º ½ÉÆ÷Áö¾ö : 2024-06-22 0 7 2024-06-14
20979 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22 0 6 2024-06-14
20978 ÀüºÏ Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22 0 7 2024-06-14
20977 Á¦ÁÖ ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22 0 6 2024-06-14
20976 ±¤ÁÖ 2024³â »ó¹Ý±â ±¤ÁÖ±¤¿ª½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 14 2024-06-14
20975 ¼­¿ï 2024³â ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-21 0 5 2024-06-14
20974 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 SNUH Rare Disease Workshop : 2024-06-21 0 4 2024-06-14
20973 °­¿ø 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Á¦21Â÷ ¿öÅ©¼ó : 2024-06-21 0 8 2024-06-14
20972 ¼­¿ï Á¦23ȸ Çѱ¹Á¤¸Æ°æÀ念¾çÇÐȸ Çмú´ëȸ ¹× 2024 ±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-21 0 7 2024-06-14
20971 ¼­¿ï ´ëÇѼҾƳ»ºÐºñÇÐȸ 2024³â Á¦1Â÷ Á¤±âÁý´ãȸ(°íÇÁ·Î¶ôƾÇ÷Áõ) : 2024-06-21 0 4 2024-06-14
20970 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 2Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-21 0 2 2024-06-14
20969 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(1ÀÏÂ÷) : 2024-06-21 0 2 2024-06-14
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷